Founded in 2012, DIA-UP has a professional R&D team with over 10 years of experience and has been awarded a number of invention patents. The company has established five core technology platforms, including the In Vitro Diagnostic (IVD) Raw Material R&D Platform (covering 10 major product systems： primer and probe synthesis, nucleic acid molecular detection raw materials, immunoassay reagent raw materials, biochemical reagent raw materials, coagulation reagent raw materials, fluorescent immunochromatographic POCT large plates, large-volume biochemical reagents, large-volume coagulation reagents, and calibration & quality control materials), the Automated High-Throughput DNA Reading and Writing Platform, the Intelligent RNA Design and Synthesis Platform, the Protein Antibody Preparation Platform, and the Scientific Research Reagent and Consumable Supply Platform.
DIA-UP carries out product production and packaging in 100,000-class / 10,000-class clean workshops. It strictly implements the ISO13485：2016 Quality Management System standards, upholds the development philosophy of Craftsmanship Quality, Empowering Customers, and is committed to continuously providing high-quality products and services for customers in the fields of in vitro diagnostics (IVD) and scientific research.
